Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits the Hedgehog signaling pathway by direct binding to the Smoothened receptor, thereby influencing downstream factors including Dll proteins. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Specifically binds to and inhibits Smoothened, a critical component of the Hedgehog signaling pathway, affecting Dll protein expression indirectly. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt production by inhibiting Porcupine, a membrane-bound O-acyltransferase, thus potentially downregulating Dll protein activity. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
Inhibits Wnt ligand secretion and activity by targeting Porcupine, thereby modulating Dll-related pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Selectively inhibits the activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7, affecting TGF-β signaling and potentially Dll protein activity. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Blocks BMP signaling by inhibiting BMP type I receptors ALK2 and ALK3, which can influence Dll expression. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Inhibits BMP signaling through ALK2, ALK3, and ALK6 receptors, affecting the transcriptional activity of Dll proteins. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt signaling by stabilizing axin and promoting β-catenin degradation, potentially modulating Dll protein levels. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
Acts as an antagonist of the Wnt/β-catenin signaling pathway by inhibiting the activity of PARP domain of tankyrase 1 and 2, thereby influencing Dll. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Inhibits GSK-3β leading to activation of Wnt signaling; this paradoxical activation might still modulate Dll protein expression in certain contexts. | ||||||